FDA DEVICE FACTS
INCRAFT(R) AAA STENT GRAFT SYSTEM
Cordis US Corporation
Verified FDA Record identity for medical-device development research. This overview uses only fields stated in the FDA Record and is not a Device Description.医療機器開発の調査用に、確認済みの FDA Record の識別情報を示しています。この概要は FDA Record に記載された項目だけによるもので、機器説明ではありません。
Indications for use
The INCRAFT® AAA Stent Graft System (INCRAFT) is intended for the endovascular treatment of patients with infrarenal abdominal aortic aneurysms with the following characteristics:
• Adequate, but complex iliac or femoral vessel morphology (e.g., high tortuosity index, heavily calcified, small diameter), that is compatible with vascular access techniques, devices or accessories;
• Proximal neck length ≥ 10 mm;
• Aortic neck diameters ≥ 17 mm and ≤ 31 mm;
• Aortic neck suitable for suprarenal fixation;
• Infrarenal and suprarenal neck angulation ≤ 60°;
• Iliac fixation length ≥ 15 mm;
• Iliac diameters ≥ 7 mm and ≤ 22 mm; and
• Minimum overall AAA treatment length (proximal landing location to distal landing location) ≥ 128 mm.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。